OrbiMed’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-550,114
| Closed | -$54.2M | – | 156 |
|
2021
Q1 | $54.2M | Hold |
550,114
| – | – | 0.51% | 55 |
|
2020
Q4 | $59.6M | Buy |
550,114
+91,680
| +20% | +$9.94M | 0.52% | 54 |
|
2020
Q3 | $47.2M | Buy |
458,434
+129,360
| +39% | +$13.3M | 0.59% | 54 |
|
2020
Q2 | $68.7M | Sell |
329,074
-15,990
| -5% | -$3.34M | 0.97% | 31 |
|
2020
Q1 | $33.7M | Sell |
345,064
-89,155
| -21% | -$8.71M | 0.57% | 47 |
|
2019
Q4 | $50M | Buy |
434,219
+32,922
| +8% | +$3.79M | 0.71% | 45 |
|
2019
Q3 | $21.9M | Buy |
401,297
+205,277
| +105% | +$11.2M | 0.42% | 57 |
|
2019
Q2 | $23.3M | Buy |
196,020
+71,700
| +58% | +$8.53M | 0.36% | 61 |
|
2019
Q1 | $6.51M | Buy |
+124,320
| New | +$6.51M | 0.1% | 94 |
|
2015
Q3 | – | Hold |
0
| – | – | – | 130 |
|
2015
Q2 | – | Sell |
-28,390
| Closed | -$11.5M | – | 126 |
|
2015
Q1 | $11.5M | Buy |
+28,390
| New | +$11.5M | 0.1% | 93 |
|